Literature DB >> 17072913

Anti-cytokine vaccines and the immunotherapy of autoimmune diseases.

David C Wraith1.   

Abstract

Three papers in this issue of the European Journal of Immunology describe the use of cytokine vaccines to prevent autoimmune disease in experimental animals. The vaccines are based on interleukin 17 (IL-17), a cytokine that has recently been shown to play a central role in inflammation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17072913      PMCID: PMC2615480          DOI: 10.1002/eji.200636760

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  33 in total

Review 1.  The molecular basis of T helper 1 and T helper 2 cell differentiation.

Authors:  A O'Garra; N Arai
Journal:  Trends Cell Biol       Date:  2000-12       Impact factor: 20.808

2.  Cutting edge: roles of Toll-like receptor 4 and IL-23 in IL-17 expression in response to Klebsiella pneumoniae infection.

Authors:  Kyle I Happel; Mingquan Zheng; Erana Young; Lee J Quinton; Euan Lockhart; Alistair J Ramsay; Judd E Shellito; Jill R Schurr; Gregory J Bagby; Steve Nelson; Jay K Kolls
Journal:  J Immunol       Date:  2003-05-01       Impact factor: 5.422

3.  Understanding the IL-23-IL-17 immune pathway.

Authors:  Brent S McKenzie; Robert A Kastelein; Daniel J Cua
Journal:  Trends Immunol       Date:  2005-11-14       Impact factor: 16.687

Review 4.  Rationale and safety of anti-interleukin-23 and anti-interleukin-17A therapy.

Authors:  Edward P Bowman; Alissa A Chackerian; Daniel J Cua
Journal:  Curr Opin Infect Dis       Date:  2006-06       Impact factor: 4.915

Review 5.  Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases.

Authors:  R S Liblau; S M Singer; H O McDevitt
Journal:  Immunol Today       Date:  1995-01

6.  The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells.

Authors:  Ivaylo I Ivanov; Brent S McKenzie; Liang Zhou; Carlos E Tadokoro; Alice Lepelley; Juan J Lafaille; Daniel J Cua; Dan R Littman
Journal:  Cell       Date:  2006-09-22       Impact factor: 41.582

Review 7.  Regulatory CD4+ T cells and the control of autoimmune disease.

Authors:  David C Wraith; Kirsty S Nicolson; Nathaniel T Whitley
Journal:  Curr Opin Immunol       Date:  2004-12       Impact factor: 7.486

8.  T helper cell subsets in insulin-dependent diabetes.

Authors:  J D Katz; C Benoist; D Mathis
Journal:  Science       Date:  1995-05-26       Impact factor: 47.728

9.  TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells.

Authors:  Marc Veldhoen; Richard J Hocking; Christopher J Atkins; Richard M Locksley; Brigitta Stockinger
Journal:  Immunity       Date:  2006-02       Impact factor: 31.745

10.  A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis.

Authors:  Caroline Sutton; Corinna Brereton; Brian Keogh; Kingston H G Mills; Ed C Lavelle
Journal:  J Exp Med       Date:  2006-07-03       Impact factor: 14.307

View more
  4 in total

Review 1.  Genetic and Molecular Biology of Multiple Sclerosis Among Iranian Patients: An Overview.

Authors:  Meysam Moghbeli
Journal:  Cell Mol Neurobiol       Date:  2019-09-03       Impact factor: 5.046

2.  Update on Targets of Biologic Therapies for Rheumatoid Arthritis.

Authors:  Zafar Rasheed; Tariq M Haqqi
Journal:  Curr Rheumatol Rev       Date:  2008-11-01

3.  Both Th1 and Th17 are immunopathogenic but differ in other key biological activities.

Authors:  Catherine A Cox; Guangpu Shi; Hongen Yin; Barbara P Vistica; Eric F Wawrousek; Chi-Chao Chan; Igal Gery
Journal:  J Immunol       Date:  2008-06-01       Impact factor: 5.422

4.  Multifactorial Design of a Supramolecular Peptide Anti-IL-17 Vaccine Toward the Treatment of Psoriasis.

Authors:  Lucas S Shores; Sean H Kelly; Kelly M Hainline; Jutamas Suwanpradid; Amanda S MacLeod; Joel H Collier
Journal:  Front Immunol       Date:  2020-08-18       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.